Guaimesal

Guaimesal is a new antiphlogistic and mucus-regulating agent. Guaimesal improves bronchitis symptoms[1][2].

Product Specifications

CAS Number

[81674-79-5]

Product Name Alternative

Brontermil

UNSPSC

12352005

Target

Mucin

Related Pathways

Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Smiles

O=C1C2=CC=CC=C2OC(OC3=CC=CC=C3OC)(C)O1

Molecular Formula

C16H14O5

Molecular Weight

286.28

References & Citations

[1]Jager EG. Double-blind, placebo-controlled clinical evaluation of guaimesal in outpatients. Clin Ther. 1989 May-Jun;11 (3) :341-62. |[2]Bandera M, et al. Valutazione clinica dell'afficacia terapeutica di un nuovo farmaco ad attività antiflogistica e mucoregolatrice, il guaimesal, nelle broncopneumopatie acute e croniche [Clinical evaluation of the therapeutic efficacy of a new antiphlogistic and mucus-regulating drug, guaimesal, in acute and chronic bronchopneumopathies]. Clin Ter. 1984 Sep 15;110 (5) :455-61. Italian.